top
Please input keywords
YH012


YH012 is a bispecific ADC developed using our RenLite platform, which are intended for the treatment of solid tumor. YH012 is currently at discovery stage.
naver-site-verification: naver8a6b0412e3d2d9dd38f1684b831435ac.html